Phase III Results Of Injectable Abilify Positive
This article was originally published in PharmAsia News
Executive Summary
Danish drug maker Lundbeck and Otsuka Holdings announced an extended non-relapse period of monthly Abilify (aripiprazole) injections for maintenance treatment of schizophrenia.